HMS (Medrysone Ophthalmic) - Summary

HMS SUMMARY

HMS^®
(medrysone ophthalmic suspension) 1%

HMS^® (medrysone ophthalmic suspension) 1% is a topical anti-inflammatory agent for ophthalmic use.

HMS^® (medrysone ophthalmic suspension) is indicated for the treatment of allergic conjunctivitis, vernal conjunctivitis, episcleritis, and epinephrine sensitivity.

See all HMS indications & dosage >>

HMS NEWS HIGHLIGHTS

Media Articles Related to HMS (Medrysone Ophthalmic)

Molecular Partnership Controls Daily Rhythms, Body Metabolism
Source: Clinical Trials / Drug Trials News From Medical News Today [2008.11.27]

Chronotherapy - Tunes In to Body's Rhythms
Source: MedicineNet Biorhythms Specialty [2004.07.06]

Body Rhythms and Asthma
Source: MedicineNet Biorhythms Specialty [2002.07.23]

52 Percent Of Newly Diagnosed Bipolar Disorder Patients Receive Antidepressant Drugs In First-Line Treatment
Source: Bipolar News From Medical News Today [2008.09.16]

more >>

Published Studies Related to HMS (Medrysone Ophthalmic)

Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study. [2005.05.17]

Hyper reactive malarial splenomegaly (HMS). [2006.07]

more >>

Clinical Trials Related to HMS (Medrysone Ophthalmic)

Safety and Efficacy of Lidocaine Infiltration in Suction Assisted Lipectomy [Enrolling by invitation]

Open Trial of Miglitol in Type 1 Diabetic Patients With Insulin Treatment [Completed]

Impact of Sleep Disruption on the Menstrual Cycle [Recruiting]

Pilot Study to Test the Effectiveness of Combining Conventional and Complementary Medicine to Treat Low Back Pain [Recruiting]

A Randomized Trial of Base-in Prism Reading Glasses Convergence Insufficiency in Children [Completed]

more >>